Catalent Total Assets 2012-2019 | CTLT

Catalent total assets from 2012 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Catalent total assets for the quarter ending September 30, 2019 were $6.120B, a 35.99% increase year-over-year.
  • Catalent total assets for 2019 were $6.184B, a 36.48% increase from 2018.
  • Catalent total assets for 2018 were $4.531B, a 31.17% increase from 2017.
  • Catalent total assets for 2017 were $3.454B, a 11.75% increase from 2016.
Catalent Annual Total Assets
(Millions of US $)
2019 $6,184
2018 $4,531
2017 $3,454
2016 $3,091
2015 $3,138
2014 $3,090
2013 $2,950
2012 $3,139
2011 $0
Catalent Quarterly Total Assets
(Millions of US $)
Q1 2019 $6,120
Q4 2019 $6,184
Q3 2019 $4,493
Q2 2018 $4,442
Q1 2018 $4,500
Q4 2018 $4,531
Q3 2018 $4,554
Q2 2017 $4,387
Q1 2017 $3,785
Q4 2017 $3,454
Q3 2017 $3,285
Q2 2016 $3,154
Q1 2016 $3,128
Q4 2016 $3,091
Q3 2016 $3,058
Q2 2015 $3,035
Q1 2015 $3,056
Q4 2015 $3,138
Q3 2015 $2,974
Q2 2014 $3,038
Q1 2014 $2,951
Q4 2014 $3,090
Q3 2014 $3,091
Q2 2013 $3,057
Q1 2013 $0
Q4 2013 $2,950
Q3 2013 $0
Q4 2012 $3,139
Q4 2011 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.377B $2.518B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.496B 10.03
Zoetis (ZTS) United States $56.165B 33.60
Astellas Pharma (ALPMY) Japan $31.345B 15.66
Eisai (ESALY) Japan $18.870B 36.39
Merck (MKGAF) Germany $15.276B 20.85
Grifols, S.A (GRFS) Spain $14.913B 19.03
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.411B 491.52
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.953B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.244B 16.70
Jazz Pharmaceuticals (JAZZ) Ireland $7.843B 10.02
Sage Therapeutics (SAGE) United States $7.582B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.134B 18.45
Arrowhead Pharmaceuticals (ARWR) United States $4.498B 103.13
United Therapeutics (UTHR) United States $3.968B 0.00
Nektar Therapeutics (NKTR) United States $3.457B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.363B 12.29
FibroGen (FGEN) United States $3.227B 94.85
Evotec AG (EVTCY) Germany $3.081B 50.42
PTC Therapeutics (PTCT) United States $2.693B 0.00
Portola Pharmaceuticals (PTLA) United States $2.117B 0.00
Xencor (XNCR) United States $2.041B 62.03
Tilray (TLRY) Canada $1.998B 0.00
Zogenix (ZGNX) United States $1.998B 0.00
Heron Therapeutics (HRTX) United States $1.943B 0.00
Corcept Therapeutics (CORT) United States $1.879B 22.83
Ironwood Pharmaceuticals (IRWD) United States $1.800B 57.40
Pacira Pharmaceuticals (PCRX) United States $1.791B 52.99
USANA Health Sciences (USNA) United States $1.560B 16.65
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.232B 20.33
Radius Health (RDUS) United States $1.108B 0.00
Endo (ENDP) Ireland $1.027B 1.89
Theravance Biopharma (TBPH) Cayman Islands $1.013B 0.00
Karyopharm Therapeutics (KPTI) United States $0.980B 0.00
ArQule (ARQL) United States $0.951B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.938B 0.00
Aerie Pharmaceuticals (AERI) United States $0.877B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.823B 5.61
Organogenesis Holdings (ORGO) United States $0.758B 0.00
TherapeuticsMD (TXMD) United States $0.743B 0.00
Flexion Therapeutics (FLXN) United States $0.614B 0.00
Collegium Pharmaceutical (COLL) United States $0.607B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ChemoCentryx (CCXI) United States $0.513B 0.00
ImmunoGen (IMGN) United States $0.495B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.492B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.459B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.458B 55.50
Crinetics Pharmaceuticals (CRNX) United States $0.450B 0.00
OptiNose (OPTN) United States $0.433B 0.00
Dermira (DERM) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.402B 9.19
Akebia Therapeutics (AKBA) United States $0.400B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.392B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.389B 16.78
Recro Pharma (REPH) United States $0.389B 0.00
Indivior (INVVY) United States $0.387B 1.40
Ardelyx (ARDX) United States $0.386B 0.00
DURECT (DRRX) United States $0.373B 0.00
Innate Pharma SA (IPHYF) France $0.372B 0.00
Lannett Co Inc (LCI) United States $0.369B 4.29
Harpoon Therapeutics (HARP) United States $0.339B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.288B 0.00
GlycoMimetics (GLYC) United States $0.270B 0.00
Molecular Templates (MTEM) United States $0.268B 0.00
Rafael Holdings (RFL) United States $0.258B 0.00
Xeris Pharmaceuticals (XERS) United States $0.222B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.209B 0.00
KalVista Pharmaceuticals (KALV) United States $0.197B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.37
Calithera Biosciences (CALA) United States $0.188B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.187B 0.00
Jounce Therapeutics (JNCE) United States $0.174B 2.33
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.163B 0.00
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Aquestive Therapeutics (AQST) United States $0.150B 0.00
Redhill Biopharma (RDHL) Israel $0.137B 0.00
MEI Pharma (MEIP) United States $0.135B 0.00
Ocular Therapeutix (OCUL) United States $0.135B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.134B 0.00
CV Sciences (CVSI) United States $0.134B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.131B 0.00
IMV INC (IMV) Canada $0.126B 0.00
CannTrust Holdings (CTST) Canada $0.124B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.092B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.076B 0.00
Otonomy (OTIC) United States $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 22.05
Generex Biotechnology (GNBT) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.062B 0.00
Natural Alternatives (NAII) United States $0.061B 15.18
Genocea Biosciences (GNCA) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.053B 0.00
Novan (NOVN) United States $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
Capnia (SLNO) United States $0.049B 0.00
Nivalis Therapeutics (ALPN) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Mast Therapeutics (SVRA) United States $0.030B 0.00
Biomerica (BMRA) United States $0.029B 0.00
IsoRay (ISR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.001B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00